LONDON (Reuters) - A drug for the treatment of opioid-induced constipation, MOVENTIG, from AstraZeneca, was recommended for approval by European regulators on Friday. Recommendations for marketing approval by the agency's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months. The drug is used for treating opioid-induced constipation in adult patients who have had an inadequate response to laxatives. ...
via Health News Headlines - Yahoo News http://ift.tt/YiqQGL
via Health News Headlines - Yahoo News http://ift.tt/YiqQGL
No comments:
Post a Comment